The ovarian cancer market has transformed in recent years, driven by the expanding use of PARP inhibitors, antiangiogenic ...

The malignant ovarian cysts that characterize ovarian cancer are rare, and only 13 to 21 percent of ovarian cysts that are removed are cancerous, according to research. Unusual symptoms can be a ...

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and ...

The patient recovered well and was discharged 10 days later, with her weight dropping from 116 kg to 96 kg post-surgery.

Platinum-based chemotherapy: A cancer treatment regimen that uses platinum compounds, such as cisplatin, which are highly effective in inducing tumour regression. Malignant Ovarian Germ Cell ...

Ovarian cancer mortality has declined ... They identified female patients with malignant neoplasm of the ovary (International Classification of Diseases, 10 th Edition, code C56), stratifying ...

If you have ovarian cancer, there’s a good chance that at some point you’ll experience a complication — a problem or side effect of either the disease or treatment. (1) These complications ...

Relacorilant, a selective glucocorticoid receptor antagonist, combined with nab-paclitaxel significantly improved progression-free survival in women with platinum-resistant ovarian cancer.

Ovarian cancer has earned the terrifying nickname “the silent killer” because it’s notorious for causing vague, easily dismissed symptoms that women often attribute to stress, aging ...